No conflicts of interest were declared.
Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle
Article first published online: 9 JUL 2013
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
The Journal of Pathology
Volume 230, Issue 4, pages 399–409, August 2013
How to Cite
Vockerodt, M., Wei, W., Nagy, E., Prouzova, Z., Schrader, A., Kube, D., Rowe, M., Woodman, C. B. and Murray, P. G. (2013), Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. J. Pathol., 230: 399–409. doi: 10.1002/path.4198
- Issue published online: 9 JUL 2013
- Article first published online: 9 JUL 2013
- Accepted manuscript online: 16 APR 2013 12:54PM EST
- Manuscript Accepted: 11 APR 2013
- Manuscript Revised: 22 MAR 2013
- Manuscript Received: 11 JAN 2013
|path4198-sup-0001-Appendix S1.doc||Word document||44K||Appendix S1. Supplementary materials and methods|
|path4198-sup-0002-Figure S1.tif||TIFF image||617K||Phenotype of enriched CD10+ germinal centre B cells. Flow-cytometric analysis of tonsillar mononuclear cells after enrichment for CD10. (A) Cells were stained for CD10 or CD19 together with CD24. (B) Cells were stained for CD10, CXCR4 and CD83. (C) Cells were stained for CXCR4 and CD77|
|path4198-sup-0003-Figure S2.tif||TIFF image||2366K||Expression of LMP2A in primary human germinal centre B cells. (A) Flow-cytometric analysis of CD10+ tonsillar B cells transfected with pSG5 (left) or LMP2A (right), together with pMACSLNGFR and stained for CD10 and NGFR prior to sorting (B) Detection of LMP2A and β-actin in transfected CD10+ tonsillar B cells by immunoblot analysis prior to sorting|
|path4198-sup-0004-Figure S3.pdf||PDF document||262K||LMP2A and BCR activation regulate a common subset of target genes in primary human GC and BL2 cells. LMP2A target genes were compared with those genes shown to be differentially expressed in BCR crosslinked GC cells compared to unstimulated cells. (A) 323 genes were up-regulated by LMP2A in GC B cells and 1536 in stimulated GC B cells. Genes up-regulated following BCR activation were substantially enriched for those up-regulated by LMP2A [odds ratio (OR) = 16, p < 0.0001]. (B) 463 genes were down-regulated by LMP2A in GC B cells and 1572 in stimulated GC B cells. Genes down-regulated by BCR activation were enriched for those down-regulated by LMP2A (OR = 14.7, p < 0.0001). (C) qRT–PCR of the relative quantity of CCL3, CCL4, XBP1 and AID in LMP2A-expressing and control-transfected CD10+ GC B cells in two different tonsil samples (left panels), or following BCR crosslinking or CD40 stimulation in GC B cells (right panels). (D) Expression of these genes in LMP2A transfected BL2 cells. (E) Real-time RT–PCR of the relative quantity of STAT1, IFITM1, IFI6, HERC5 and CD80 in LMP2A-expressing and control-transfected CD10+ GC B cells in two different tonsil samples|
|path4198-sup-0005-Figure S4.tif||TIFF image||160K||LMP2A expression does not induces activation of the transcription factor Elk-1 in L1236 HL cells. L1236 cells were transfected with pSG5, pSG5–LMP2A or pFC–MEKK1 together with pFA–Elk1 and pFR–Luc. Relative luciferase activity was determined 24 h post-transfection. The results are the mean of three independent experiments (± SD)|
|path4198-sup-0006-Figure S5.tif||TIFF image||826K||Overlap between transcriptional targets of LMP1, LMP2A, BCR crosslink and primary HRS cells compared to centrocytes. LMP2A and BCR target genes were compared with those genes shown to be differentially expressed in HRS cells compared to centrocytes and LMP1-expressing GC B cells. (A) 258 genes were up-regulated by LMP2A and BCR crosslink in GC B cells and 172 by LMP1 and in HRS cells compared to centrocytes. (B) 235 genes were down-regulated by LMP2A and BCR crosslink in GC B cells and 537 by LMP1 and in HRS cells compared to centrocytes|
|path4198-sup-0007-Table S1.xlsx||Excel 2007 spreadsheet||68K||Genes significantly up- or down- regulated by LMP2A in GC B cells with fold change > 1.3 and p value < 0.01.|
|path4198-sup-0008-Table S2.xlsx||Excel 2007 spreadsheet||236K||Genes significantly up- or down- regulated by BCR in GC B cells with fold change > 1.3 and p value < 0.01.|
|path4198-sup-0009-Table S3.xlsx||Excel 2007 spreadsheet||25K||List of genes that are concordantly regulated by LMP2A and BCR in GC B cells.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.